SLI
2.019,73
PKT
+2,47
PKT
+0,12
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.09.24 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 26.09.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 26.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 26.09.24 | Richemont Sector Perform | RBC Capital Markets | |
| 24.09.24 | Richemont Buy | UBS AG | |
| 24.09.24 | Swatch (I) Sell | UBS AG | |
| 24.09.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 24.09.24 | ams-OSRAM Buy | UBS AG | |
| 24.09.24 | ams-OSRAM Buy | UBS AG | |
| 23.09.24 | Nestlé Sector Perform | RBC Capital Markets | |
| 20.09.24 | Richemont Buy | Jefferies & Company Inc. | |
| 20.09.24 | Givaudan Hold | Deutsche Bank AG | |
| 20.09.24 | Nestlé Neutral | UBS AG | |
| 20.09.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 19.09.24 | Zurich Insurance Overweight | Barclays Capital | |
| 19.09.24 | Zurich Insurance Overweight | Barclays Capital | |
| 19.09.24 | Swiss Re Equal Weight | Barclays Capital | |
| 19.09.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.09.24 | ams-OSRAM Equal Weight | Barclays Capital | |
| 18.09.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 18.09.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 18.09.24 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 18.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.09.24 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 18.09.24 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 17.09.24 | Givaudan Neutral | UBS AG | |
| 17.09.24 | Givaudan Neutral | UBS AG | |
| 17.09.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 17.09.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 17.09.24 | Richemont Overweight | Barclays Capital | |
| 16.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 16.09.24 | Roche Neutral | UBS AG | |
| 13.09.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 13.09.24 | Givaudan Neutral | UBS AG | |
| 13.09.24 | Roche Sell | Deutsche Bank AG | |
| 12.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 11.09.24 | Novartis Buy | UBS AG | |
| 11.09.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.09.24 | Roche Neutral | UBS AG |